Johnson & Johnson (JNJ) Tax Rate (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Tax Rate came in at 12.6% in Q1 2026, down 670.0% year-on-year from 2.21% in Q1 2025, and up 517.29% quarter-over-quarter from 3.02% in Q4 2025.
Johnson & Johnson (JNJ) Tax Rate (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Tax Rate across 18 years of filings, most recently posting 12.6% for Q1 2026.
- Tax Rate for Q1 2026 came in at 12.6%, down 670.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.64% (down 238.0% YoY), and the FY2025 annual result was 17.73%, up 202.0% from the prior year.
- Tax Rate came in at 12.6% for Q1 2026 at Johnson & Johnson, up from 3.02% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 61.85% in Q2 2023 to a low of 3.02% in Q4 2025.
- The 5-year median for Tax Rate is 16.67% (2022), against an average of 19.2%.
- Across the five-year window, Tax Rate soared 4815 bps in 2023 and tumbled 4949 bps in 2024, its largest moves.
- Johnson & Johnson's Tax Rate stood at 16.67% in 2022, then slipped by 14 bps to 14.38% in 2023, then slipped by 18 bps to 11.73% in 2024, then tumbled by 126 bps to 3.02% in 2025, then soared by 517 bps to 12.6% in 2026.
- The last three Tax Rate figures came in at 12.6% (Q1 2026), 3.02% (Q4 2025), and 31.24% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -14.23 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 16.43 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 12.60 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 32.92 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -20.26 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 12.72 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 21.67 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 14.54 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 17.31 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 12.60% |
| Mar 29, 2026 | 12.60% |
| Dec 28, 2025 | -3.02% |
| Dec 28, 2025 | -3.02% |
| Sep 28, 2025 | 31.24% |
| Sep 28, 2025 | 31.24% |
| Jun 29, 2025 | 14.70% |
| Jun 29, 2025 | 14.70% |
| Mar 30, 2025 | 19.31% |
| Mar 30, 2025 | 19.31% |
| Dec 29, 2024 | 11.73% |
| Dec 29, 2024 | 11.73% |
| Sep 29, 2024 | 19.29% |
| Sep 29, 2024 | 19.29% |
| Jun 30, 2024 | 18.48% |
| Jun 30, 2024 | 18.48% |
| Mar 31, 2024 | 12.36% |
| Mar 31, 2024 | 12.36% |
| Dec 31, 2023 | 14.38% |
| Dec 31, 2023 | 14.38% |